PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
05-Sep-2025 bonyf NV Cancels Planned Capital Increase Following Positive Strategic Developments bonyf NV
05-Sep-2025 Original-Research: Cantourage Group SE (von NuWays AG) Cantourage Group SE
05-Sep-2025 Curatis expands distribution business with Phoenix Labs with up to CHF 5m additional annual revenues Curatis Holding AG
05-Sep-2025 Newron to present data and updates on its clinical program evaluating evenamide as an add-on treatment for schizophrenia at the 2025 World Congress of Biological Psychiatry (WCBP) Newron Pharmaceuticals S.p.A.
04-Sep-2025 Sanofi’s amlitelimab met all primary and key secondary endpoints in the COAST 1 phase 3 study in adults and adolescents with atopic dermatitis Sanofi
04-Sep-2025 Immunic to Participate in Investor and Scientific Conferences in September Immunic AG
04-Sep-2025 Heidelberg Pharma Announces New Clinical Data on Lead ATAC Candidate HDP-101 to be Presented at International Myeloma Society Annual Meeting 2025 Heidelberg Pharma AG
03-Sep-2025 Straumann Holding AG raises CHF 250 million through the successful placement of a three-year straight bond Straumann Holding AG
03-Sep-2025 BRAIN Biotech AG appoints Johan Jansén-Storbacka as Executive Vice President of the BRAINBiocatalysts´ enzyme products business BRAIN Biotech AG
02-Sep-2025 Mainz Biomed Announces Registration of ColoAlert in the United Kingdom Mainz BioMed N.V.
01-Sep-2025 Marinomed Biotech AG: Agreement on the key terms of the issue of a secured EUR 2.5mn convertible bond Marinomed Biotech AG
01-Sep-2025 CEO transition at SKAN Group: Jonas Greutert to succeed Thomas Huber effective January 1, 2026 SKAN AG
01-Sep-2025 AEVIS VICTORIA SA (AEVS.SW) – Swiss Medical Network – Revenue increased by more than 20% in the first half of 2025 despite challenging conditions AEVIS VICTORIA SA
29-Aug-2025 Gerresheimer AG: Wolf Lehmann to take over CFO position at Gerresheimer on September 1, 2025 Gerresheimer AG
29-Aug-2025 Bioversys To announce its FIrst half 2025 financial results, Provide a business update And Host a Conference call BioVersys AG
28-Aug-2025 Uni-Bio Science Group Announces 2025 Interim Results UNI-BIO SCIENCE GROUP LIMITED
28-Aug-2025 Vapourtec redefines Peptide Synthesis Vapourtec
28-Aug-2025 MAQUET Medical Systems AG submitted specified squeeze-out request and has determined cash compensation for minority shareholders of Pulsion Medical Systems SE to be EUR 20.57 Pulsion Medical Systems SE
28-Aug-2025 Asklepios Group sees stable development in first half, set for closer cooperation within hospital network Asklepios Kliniken
28-Aug-2025 Gerresheimer expands financial flexibility to implement growth strategy Gerresheimer AG